The move: a bet on cell-cultivated cocoa
Mondelez's clearest supply-chain commitment in recent months is its partnership with Celleste Bio on cell-cultivated cocoa butter, the technology behind what has been described as the world's first cell-based chocolate bar. Per ConfectioneryNews coverage of the alt-chocolate space, the investment is now structural rather than pilot-scale. Nestle is working with Planet A Foods on a sunflower-based cocoa ingredient called ChoViva, and Barry Callebaut is doing the same. Cargill has gone further, bringing a fully cocoa-free alternative called NextCoa to the U.S. market in partnership with Voyage Foods, using grapeseeds and sunflower seeds to replicate chocolate's taste and texture.
Mondelez's choice of cell-cultivated cocoa butter, rather than a full cocoa-free substitute, tells you something about where the company is positioning. It is hedging on ingredient sourcing without abandoning the cocoa value chain entirely. That may reflect brand sensitivity: Cadbury, Milka, and Toblerone carry decades of consumer expectation about what chocolate tastes like. A gradual cocoa-butter substitution is lower-risk than a full reformulation.
Why now: cocoa costs and crop uncertainty
Cocoa prices hit record highs last year as climate challenges in West Africa disrupted supply, per Food Dive reporting on the Cargill-Voyage Foods launch. That pressure ran directly into Mondelez's cost base through the first quarter of 2026.
CEO Dirk Van de Put offered a partial reprieve on the April 29 earnings call. He described the mid-year cocoa crop as "quite positive," suggesting some easing of input cost pressure in the second half of 2026, per ConfectioneryNews coverage of the call. But the longer-term supply picture remains uncertain enough that the capital commitment to Celleste Bio looks like a genuine hedge, not a PR exercise.
What the numbers say
Group organic net revenue growth came in at 6.3% in Q1 2026, per ConfectioneryNews coverage of the Q1 2026 results. Beneath that headline the story is more cautious. Developed markets contributed only 0.8% organic growth alongside a 1.2% volume decline. Emerging markets added a 0.5% volume and mix gain. The company reaffirmed full-year 2026 guidance at flat to plus 2% topline growth.
Those numbers matter for the supply-chain conversation because margin defense, not top-line acceleration, is what drives sourcing decisions in this environment. When volumes in your largest and most profitable markets are declining, you have less room to absorb input cost spikes. The Celleste Bio partnership and the broader investment in cocoa alternatives are, in part, an attempt to buy future optionality on the cost side.
Separately, Mondelez entered a new 364-day senior unsecured revolving credit agreement on February 18, 2026, replacing a $1.5 billion facility it terminated at the same time, per the 8-K filed on that date. Maintaining liquidity headroom while input costs are elevated and volumes are soft is straightforward financial hygiene, but it also signals that the company is keeping its balance sheet flexible for potential supply-chain investment.
The packaging risk that no one is talking about loudly
There is a second supply-chain exposure that sits mostly off the Mondelez investor narrative but is live across the category. Naphtha, a petroleum-derived chemical used in the inks, films, coatings, and adhesives inside flexible food packaging, is under supply pressure because of Middle East conflict disrupting shipping. Per FoodNavigator and Bakery and Snacks reporting, Calbee in Japan has already switched 14 products to black-and-white packaging as a direct response.
Mondelez has not disclosed a specific packaging contingency in its public filings. But the risk is real and shared. The deep colours of KitKat, the metallic finishes on premium gifting lines, the branded films across the Oreo and Cadbury ranges all depend on the same petrochemical inputs that are now under pressure. If the naphtha shortage deepens, you would expect either cost pass-through into packaging suppliers or a visible change in pack presentation. Neither outcome is comfortable in a market where, as Van de Put noted, consumers are "a lot more anxious about how and where they are spending their money."
How this fits the consumer and competitive backdrop
The demand-side context makes the supply-chain choices harder. Van de Put described European consumer confidence as "stable but fragile" and U.S. consumer confidence as "quite low" and expected to deteriorate, per ConfectioneryNews Q1 2026 coverage. Shoppers are switching to own-label products and spending longer comparing prices, per Bakery and Snacks reporting on the Iran conflict's effect on consumer spending.
Competitors are moving on multiple fronts. Mars completed the Kellanova acquisition, significantly broadening its reach into global snacking staples such as Pringles, Pop-Tarts, and Cheez-It, per ConfectioneryNews coverage of Mars's strategy. That gives Mars a more diversified sourcing base and a wider spread of commodity exposures. Nestle and Barry Callebaut are both already working with Planet A Foods on the ChoViva sunflower-based cocoa ingredient. On the ethical sourcing side, Tony's Chocolonely posted €240 million in revenue in 2025 with 20% annual growth, per ConfectioneryNews coverage of Tony's results, demonstrating that supply-chain transparency can itself be a commercial advantage with certain shoppers.
What to watch next
Three things are worth tracking over the next two quarters. First, whether the "quite positive" mid-year cocoa crop Van de Put referenced actually translates into a measurable input cost reduction, or whether logistics and currency moves eat the benefit before it reaches the margin line. Second, how far the naphtha and flexible packaging shortage spreads: if Mondelez faces visible packaging constraints, it will need to decide quickly whether to absorb the cost or pass it on. Third, the pace at which Celleste Bio's cell-cultivated cocoa butter moves from partnership to commercial scale. Right now, Mondelez's alternative cocoa investment is ahead of consumer adoption. The gap between the two will determine whether this is a genuine resilience move or a long-horizon science project.